Skip to content

Tenofovir treatment raises the risk of broken bones

Alvaro Borges presenting at CROI 2016. Image credit: www.croiwebcasts.org

HIV-infected vaginal cells do not transmit HIV if plasma viral load is undetectable, researchers find

African Americans have highest HIV incidence, lowest rate of consistent care

Women under-represented in HIV clinical trials

Combination nanotherapy drastically reduces the amount of HIV produced by cells in mice

Tenofovir resistance may develop in more than half of patients failing treatment in sub-Saharan Africa

People taking a large number of non-HIV-related medications more likely to stop or change HIV drugs

D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease

Two cases of PrEP failure on solo tenofovir pose significant research questions